Surgical Management of Endo-Perio Lesion with Demineralised Bone Matrix in Combination of Platelet Rich Fibrin: A Case Report

Case Report

J Dent & Oral Disord. 2016;2(3): 1014.

Surgical Management of Endo-Perio Lesion with Demineralised Bone Matrix in Combination of Platelet Rich Fibrin: A Case Report

Kale P¹, Talesara K², Patil KP² and Nayyar AS³*

¹Department of Conservative Dentistry & Endodontics, Dr. D.Y. Patil Dental College & Hospital, India

²Department of Periodontics and Oral Implantology, Dr. D.Y. Patil Dental School, India

³Department of Oral Medicine and Radiology, Saraswati- Dhanwantari Dental College and Hospital and Post- Graduate Research Institute, India

*Corresponding author: Nayyar AS, Department of Oral Medicine and Radiology, Saraswati-Dhanwantari Dental College and Hospital and Post-Graduate Research Institute, India

Received: February 17, 2016; Accepted: May 02, 2016; Published: May 03, 2016

Abstract

Periodontal disease is an inflammatory disease leading to periodontal attachment loss and bone destruction. The objective of periodontal therapy is to regenerate the lost periodontal supporting tissues. Platelets are rich in growth factors that may contribute to an accelerated process of tissue regeneration. Demineralised Bone Matrix (DMBM) Xenograft is a bone inductive sterile bioresorbable Xenograft composed of Type I collagen. Given the unique properties of autologous Platelet Rich Fibrin (PRF) and already demonstrated regenerative capacity of commercially available bone grafts, application of a combination approach was attempted. We present here a case report with an eight month follow-up report of a combined endo-perio lesion, which was treated by means of combination of autologous PRF with bovine derived xenograft, and assessed clinically and radiographically.

Keywords: Periodontal disease; Periodontal therapy; Demineralised bone matrix (DMBM); Xenograft; Platelet rich fibrin (PRF); Bone grafts

Introduction

Periodontal disease is an inflammatory disease leading to periodontal attachment loss and bone destruction. The objective of periodontal therapy is to regenerate the lost periodontal supporting tissues. However, periodontal regeneration requires a sequence of biological events including cell adhesion, migration, proliferation and differentiation [1]. A combination of growth factors may more effectively stimulate formation of mineralized as well as non mineralized tissues [2]. Platelets are rich in growth factors that may contribute to an accelerated process of tissue regeneration. During the early stages of wound healing, platelets released growth factors, including platelet derived growth factor, insulin like growth factor-1 and transforming growth factor-β, initiate a cascade of cellular and molecular events that result in wound healing in a highly regulated and coordinated manner [2]. The application of these growth factors to bone and periodontal regeneration has been investigated using numerous in-vitro and in-vivo models with promising results [3- 6]. Xenografts used in the treatment of infrabony defects can be both bovine bone and natural coral, these are also referred to as anorganic bone, since they are suggested to remove all cells and proteinaceous material leaving behind an inert absorbable bone scaffolding upon which revascularization, osteoblasts migration, and woven bone formation supposedly occurs [7]. Demineralised Bone Matrix (DMBM) Xenograft is a bone inductive sterile bioresorbable Xenograft composed of Type I collagen. It is prepared from bovine cortical samples, resulting in non-immunogenic flowable particles of approximately 250 μm dimensions that are completely replaced by host bone in 4-24 weeks [8]. Platelet-Rich fibrin (PRF) described by Choukroun et al. is a second-generation platelet concentrate which allows one to obtain fibrin membranes enriched with platelets and growth factors, after starting from an anticoagulant-free blood harvest without any artificial biochemical modification [9]. The PRF clot forms a strong natural fibrin matrix, which concentrates almost all the platelets and growth factors of the blood harvest and shows a complex architecture as a healing matrix, including mechanical properties no other platelet concentrate offers [10-11]. It is an autologous biomaterial which has found numerous clinical applications which have been described in the specializations of oral maxillofacial surgery [12-14] and in dental implantology [15- 16]. Given the unique properties of autologous PRF and already demonstrated regenerative capacity of commercially available bone grafts, application of a combination approach was attempted. We present here a case report with a 12 month follow-up report of a combined endo-perio lesion, which was treated by means of combination of autologous PRF with bovine derived xenograft, and assessed clinically and radiographically.

Case Presentation

A 35 year old patient reported to the department with a chief complaint of swelling in the upper front tooth region since 2 months. The patient had reported trauma in the same region 7 years back. The nature of the pain was intermittent in nature. The patient used to take analgesics to relieve the pain. The past medical history of the patient did not reveal any significant finding and the patient was systemically healthy and was not on any medication. Patient revealed no history of smoking and alcohol and other deleterious habits. On examination, there was a swelling of about 3cm x 3cm with Ellis class IV fracture in relation to 11. The tooth appeared to be discolored (Figure 1). The pulp vitality tests revealed that the tooth was nonvital while the radiographic examination of the concerned area in the form of an Intra-Oral Peri-Apical Radiograph (IOPAR) revealed that it had a large peri-apical radiolucency (Figure 2). Periodontal probing revealed a deep periodontal pocket measuring about 15mm in depth. (Figure 3). The provisional diagnosis arrived-at was a combined endo-perio lesion in relation to 11 region.